Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

A phase II trial of oral temozolomide in patients with metastatic renal cell cancer.

Park DK, Ryan CW, Dolan ME, Vogelzang NJ, Stadler WM. A phase II trial of oral temozolomide in patients with metastatic renal cell cancer. Cancer Chemother Pharmacol. 2002 Aug; 50(2):160-2.

View in: PubMed

collapse authors with profiles